الوطن
الوطن
Ready to play
Ready to play
The new Japanese treatment for esophageal cancer relies on the use of viruses that attack tumors and multiply within them, leading to tumor breakdown and stimulating the immune system through the production of tumor antigens. This therapy differs from chemotherapy and radiation therapy and is used for patients who are not suitable for traditional treatments, with the aim of increasing survival rates and improving quality of life. It has been approved in Japan after passing through three clinical trial phases and is offered as an alternative to palliative treatments. The approach has shown promising results, although it does not constitute a definitive cure for the disease.
Notice: This Is an AI-Generated Summary
Comments (0)